Previous close | 0.0450 |
Open | 0.0440 |
Bid | 0.0430 x 0 |
Ask | 0.0460 x 0 |
Day's range | 0.0430 - 0.0460 |
52-week range | 0.0410 - 0.0940 |
Volume | |
Avg. volume | 129,024 |
Market cap | 13.177M |
Beta (5Y monthly) | 0.23 |
PE ratio (TTM) | 4.78 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
It is hard to get excited after looking at Regeneus' (ASX:RGS) recent performance, when its stock has declined 8.8...
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce a research collaboration with Professor Christopher Little and the Raymond Purves Bone and Joint Research Laboratory at the Kolling Institute at Royal North Shore Hospital, Australia.